PE117399A1 - CICATRIZACION DE FRACTURAS UTILIZANDO ANALOGOS DE PTHrP - Google Patents
CICATRIZACION DE FRACTURAS UTILIZANDO ANALOGOS DE PTHrPInfo
- Publication number
- PE117399A1 PE117399A1 PE1998000838A PE00083898A PE117399A1 PE 117399 A1 PE117399 A1 PE 117399A1 PE 1998000838 A PE1998000838 A PE 1998000838A PE 00083898 A PE00083898 A PE 00083898A PE 117399 A1 PE117399 A1 PE 117399A1
- Authority
- PE
- Peru
- Prior art keywords
- pthrp
- positions
- amino acid
- helice
- leu
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE AL USO DE UN ANALOGO POLIPEPTIDICO RELACIONADO CON LA HORMONA PARATIROIDEA (PTHrP) QUE PRESENTA RESIDUOS DE AMINOACIDOS QUE FORMAN UNA HELICE O ANFIPATICA PARA LA PREPARACION DE UN MEDICAMENTO PARA LA CICATRIZACION DE HUESO Y REPARACION DE FRACTURAS DE PREFERENCIA DE HUESO INTRAMEMBRANOSO. LA HELICE O ANFIPATICA PRESENTA LA SIGUIENTE SECUENCIA Glu Leu Leu Glu Xaa Leu Leu Glu Lys Leu, DONDE Xaa ES LISINA O HISTIDINA; O EL ANALOGO DE PTHrP ES UNA SECUENCIA DE 34 AMINOACIDOS. O EL ANALOGO DE PTHrP POSEE AL MENOS DOS RESIDUOS DE AMINOACIDOS UNIDOS A TRAVES DE CADENAS LATERALES UBICADOS EN LAS POSICIONES 13 Y 17 O EN LAS POSICIONES 26 Y 30; O ES UNA FORMA TRUNCADA N-TERMINAL DE 30 A 50 RESIDUOS AMINOACIDOS OPCIONALMENTE SUSTITUIDA EN LAS POSICIONES 5, 13, 17, 19, 26, 30, 32 Y 34; TAMBIEN SE REFIERE AL USO DE UN SEGUNDO AGENTE CICATRIZADOR DE HUESO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5832497P | 1997-09-09 | 1997-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE117399A1 true PE117399A1 (es) | 1999-11-20 |
Family
ID=22016113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1998000838A PE117399A1 (es) | 1997-09-09 | 1998-09-07 | CICATRIZACION DE FRACTURAS UTILIZANDO ANALOGOS DE PTHrP |
Country Status (32)
Country | Link |
---|---|
US (1) | US6583114B2 (es) |
EP (1) | EP1005359B1 (es) |
JP (1) | JP2002509854A (es) |
KR (1) | KR100679778B1 (es) |
CN (1) | CN1210059C (es) |
AR (1) | AR015435A1 (es) |
AT (1) | ATE297754T1 (es) |
AU (1) | AU752925B2 (es) |
BR (1) | BR9812068A (es) |
CA (1) | CA2302255C (es) |
CO (1) | CO4890856A1 (es) |
CZ (1) | CZ298701B6 (es) |
DE (1) | DE69830591T2 (es) |
ES (1) | ES2244090T3 (es) |
HK (1) | HK1030753A1 (es) |
HR (1) | HRP20000109A2 (es) |
HU (1) | HU226866B1 (es) |
IL (2) | IL134719A0 (es) |
MA (1) | MA26545A1 (es) |
MY (1) | MY121291A (es) |
NO (1) | NO323740B1 (es) |
NZ (1) | NZ502970A (es) |
PE (1) | PE117399A1 (es) |
PL (1) | PL195703B1 (es) |
RS (1) | RS49707B (es) |
RU (1) | RU2224539C2 (es) |
SA (1) | SA98190565B1 (es) |
TR (1) | TR200000649T2 (es) |
TW (1) | TW552139B (es) |
UY (1) | UY25172A1 (es) |
WO (1) | WO1999012561A2 (es) |
ZA (1) | ZA988030B (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033950A1 (en) | 2000-09-26 | 2004-02-19 | Hock Janet M. | Method of increasing bone toughness and stiffness and reducing fractures |
EP1769804B1 (en) * | 1998-08-19 | 2012-09-19 | Eli Lilly And Company | hPTH(1-34) for use in preventing or reducing the incidence or severity of vertebral and / or non vertebral fracture in a male human |
EP1136076A1 (en) * | 1998-08-19 | 2001-09-26 | Eli Lilly And Company | Method of increasing bone toughness and stiffness and reducing fractures |
DZ2873A1 (fr) | 1998-08-19 | 2003-12-15 | Lilly Co Eli | Procédé pour augmenter la dureté et la rigidité osseuse. |
CA2245903A1 (en) * | 1998-09-28 | 2000-03-28 | Mcgill University | Use of pex in the treatment of metabolic bone diseases |
PL350917A1 (en) | 1999-03-05 | 2003-02-10 | Procter & Gamble | C16 unsaturated fp-selective prostaglandins analogs |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US6675048B2 (en) * | 2000-05-08 | 2004-01-06 | International Rehabilitative Sciences, Inc. | Electro-medical device for use with biologics |
US6560487B1 (en) | 2000-05-08 | 2003-05-06 | International Rehabilitative Sciences, Inc. | Electro-medical device for use with biologics |
US6393328B1 (en) * | 2000-05-08 | 2002-05-21 | International Rehabilitative Sciences, Inc. | Multi-functional portable electro-medical device |
CA2472472A1 (en) | 2002-01-10 | 2003-07-24 | Osteotrophin Llc | Treatment of bone disorders with skeletal anabolic drugs |
US7399826B1 (en) | 2003-10-02 | 2008-07-15 | Ali Sadat M | Peptide for promoting healing of fractures |
AU2005294125A1 (en) * | 2004-10-08 | 2006-04-20 | Transition Therapeutics Inc. | Vasoactive intestinal polypeptide pharmaceuticals |
BRPI0618469A2 (pt) * | 2005-11-10 | 2011-08-30 | Univ Michigan Tech | hormÈnio paratiróide de urso preto e métodos de uso de hormÈnio paratiróide de urso preto |
US20090022684A1 (en) * | 2006-05-09 | 2009-01-22 | Paul Morley | Methods for hematopoietic stimulation |
US7803770B2 (en) | 2006-10-03 | 2010-09-28 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
USRE49444E1 (en) | 2006-10-03 | 2023-03-07 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
ES2637283T3 (es) | 2006-10-03 | 2017-10-11 | Radius Health, Inc. | Una composición estable que comprende PTHrP y usos de la misma |
EP1961765A1 (en) * | 2006-12-08 | 2008-08-27 | Zealand Pharma A/S | Truncated PTH peptides with a cyclic conformation |
JP5564167B2 (ja) * | 2008-05-22 | 2014-07-30 | 日本たばこ産業株式会社 | 苦味マスキング剤及び苦味低減方法 |
US8870876B2 (en) | 2009-02-13 | 2014-10-28 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
CN102448482A (zh) | 2009-03-27 | 2012-05-09 | 范安德尔研究所 | 甲状旁腺素肽和甲状旁腺素相关蛋白肽及使用方法 |
US8277459B2 (en) | 2009-09-25 | 2012-10-02 | Tarsus Medical Inc. | Methods and devices for treating a structural bone and joint deformity |
CA2782640A1 (en) | 2009-12-07 | 2011-06-16 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
US8652141B2 (en) | 2010-01-21 | 2014-02-18 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
US8696719B2 (en) | 2010-06-03 | 2014-04-15 | Tarsus Medical Inc. | Methods and devices for treating hallux valgus |
CN104146961B (zh) * | 2014-07-04 | 2018-02-27 | 深圳职业技术学院 | 一种薄膜蒸发法制备载细胞因子和骨蛋白微球的方法 |
CN113288887A (zh) | 2015-04-29 | 2021-08-24 | 雷迪厄斯制药公司 | 用于治疗癌症的方法 |
CN108025042A (zh) * | 2015-07-06 | 2018-05-11 | 董正欣 | PTHrP类似物的新型制剂 |
EP3481414B1 (en) | 2016-04-18 | 2021-11-03 | Radius Health, Inc. | Formulations of abaloparatide, transdermal patches thereof, and uses thereof |
EP3565542B1 (en) | 2017-01-05 | 2024-04-10 | Radius Pharmaceuticals, Inc. | Polymorphic forms of rad1901-2hcl |
US10996208B2 (en) | 2017-04-28 | 2021-05-04 | Radius Health, Inc. | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
AU2019297421A1 (en) | 2018-07-04 | 2021-01-28 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD 1901-2HCL |
WO2021051082A1 (en) * | 2019-09-12 | 2021-03-18 | Radius Health, Inc. | Methods of improving spinal fusion with abaloparatide |
CN112646042A (zh) * | 2019-10-10 | 2021-04-13 | 陕西麦科奥特科技有限公司 | 活性多肽化合物 |
EP4274556A1 (en) * | 2021-01-05 | 2023-11-15 | Radius Health, Inc. | Treatment of long bone fractures with abaloparatide |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3935738A1 (de) * | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff |
US5977070A (en) * | 1992-07-14 | 1999-11-02 | Piazza; Christin Teresa | Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
US5821225A (en) * | 1992-07-14 | 1998-10-13 | Syntex (U.S.A.) Inc. | Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp |
US5589452A (en) * | 1992-07-14 | 1996-12-31 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
AU672790B2 (en) * | 1992-07-15 | 1996-10-17 | Novartis Ag | Variants of parathyroid hormone and its fragments |
CN1070500C (zh) * | 1993-07-13 | 2001-09-05 | 森德克斯(美国)股份有限公司 | 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途 |
WO1995011697A1 (fr) * | 1993-10-27 | 1995-05-04 | Chugai Seiyaku Kabushiki Kaisha | Accelerateur de guerison utilise en chondroplastie |
JPH08310965A (ja) * | 1995-05-16 | 1996-11-26 | Chugai Pharmaceut Co Ltd | 骨癒合促進剤 |
US5717062A (en) * | 1995-06-07 | 1998-02-10 | Beth Israel Hospital Association | Cyclic analogs of PTH and PTHrP |
US5723577A (en) * | 1995-07-13 | 1998-03-03 | Biomeasure Inc. | Analogs of parathyroid hormone |
US5955574A (en) * | 1995-07-13 | 1999-09-21 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. | Analogs of parathyroid hormone |
-
1998
- 1998-09-02 AU AU97406/98A patent/AU752925B2/en not_active Expired
- 1998-09-02 WO PCT/EP1998/005550 patent/WO1999012561A2/en active IP Right Grant
- 1998-09-02 PL PL98339449A patent/PL195703B1/pl unknown
- 1998-09-02 EP EP98951341A patent/EP1005359B1/en not_active Expired - Lifetime
- 1998-09-02 IL IL13471998A patent/IL134719A0/xx unknown
- 1998-09-02 KR KR1020007002454A patent/KR100679778B1/ko not_active IP Right Cessation
- 1998-09-02 DE DE69830591T patent/DE69830591T2/de not_active Expired - Lifetime
- 1998-09-02 RU RU2000109305/15A patent/RU2224539C2/ru active
- 1998-09-02 CN CNB988089696A patent/CN1210059C/zh not_active Expired - Lifetime
- 1998-09-02 CA CA2302255A patent/CA2302255C/en not_active Expired - Lifetime
- 1998-09-02 AT AT98951341T patent/ATE297754T1/de active
- 1998-09-02 ZA ZA988030A patent/ZA988030B/xx unknown
- 1998-09-02 CZ CZ20000862A patent/CZ298701B6/cs not_active IP Right Cessation
- 1998-09-02 BR BR9812068-9A patent/BR9812068A/pt not_active IP Right Cessation
- 1998-09-02 JP JP2000510458A patent/JP2002509854A/ja active Pending
- 1998-09-02 RS YUP-127/00A patent/RS49707B/sr unknown
- 1998-09-02 NZ NZ502970A patent/NZ502970A/en not_active IP Right Cessation
- 1998-09-02 HU HU0004560A patent/HU226866B1/hu unknown
- 1998-09-02 ES ES98951341T patent/ES2244090T3/es not_active Expired - Lifetime
- 1998-09-02 TR TR2000/00649T patent/TR200000649T2/xx unknown
- 1998-09-03 US US09/146,802 patent/US6583114B2/en not_active Expired - Lifetime
- 1998-09-07 UY UY25172A patent/UY25172A1/es not_active Application Discontinuation
- 1998-09-07 MY MYPI98004075A patent/MY121291A/en unknown
- 1998-09-07 AR ARP980104456A patent/AR015435A1/es unknown
- 1998-09-07 PE PE1998000838A patent/PE117399A1/es not_active Application Discontinuation
- 1998-09-07 CO CO98051174A patent/CO4890856A1/es unknown
- 1998-09-07 TW TW087114825A patent/TW552139B/zh not_active IP Right Cessation
- 1998-09-08 MA MA25247A patent/MA26545A1/fr unknown
- 1998-09-21 SA SA98190565A patent/SA98190565B1/ar unknown
-
2000
- 2000-02-24 IL IL134719A patent/IL134719A/en not_active IP Right Cessation
- 2000-02-29 HR HR20000109A patent/HRP20000109A2/hr not_active Application Discontinuation
- 2000-03-08 NO NO20001195A patent/NO323740B1/no not_active IP Right Cessation
-
2001
- 2001-03-12 HK HK01101739A patent/HK1030753A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE117399A1 (es) | CICATRIZACION DE FRACTURAS UTILIZANDO ANALOGOS DE PTHrP | |
JP2002509854A5 (es) | ||
RU2000109305A (ru) | ЗАЖИВЛЕНИЕ ПЕРЕЛОМОВ С ПОМОЩЬЮ АНАЛОГОВ ПЕПТИДА, ПОДОБНОГО ПАРАТИРЕОИДНОМУ ГОРМОНУ (РТНrР) | |
Glimcher et al. | The amino acid composition of the organic matrix and the neutral-soluble and acid-soluble components of embryonic bovine enamel | |
HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
ES553935A0 (es) | Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante. | |
ES2150940T3 (es) | Formulacion proteinica que comprende hormona del crecimiento. | |
ES2190244T3 (es) | Uso de la hormona paratiroidea constituida por una secuencia de aminoacidos 1-34 de la hormona paratiroidea humana para reducir el riesco de fracturas oseas vertebrales y no vertebrales. | |
CN1377371A (zh) | 用于治疗骨质疏松症的甲状旁腺激素类似物 | |
HUP9902476A2 (hu) | Növekedési hormont, aminosavat és nemionos detergenst tartalmazó gyógyászati kiszerelés előállítási eljárása | |
DE59004445D1 (de) | Arzneimittel (calcitoningen verwandte peptide) zur behandlung erektiler dysfunktionen. | |
DE60130877D1 (de) | Modifizierte peptide enthaltende pharmazeutische präparationen | |
ES2144394T3 (es) | Polipeptidos y peptidos recombinantes, acidos nucleicos que los codifican y utilizacion de dichos polipeptidos y peptidos para el diagnostico de la tuberculosis. | |
BR9811755A (pt) | Peptìdeo, processo para o tratamento da obesidade em um animal, uso de um peptìdeo, e, composição farmacêutica | |
ATE365542T1 (de) | Lyophilisierbare pharmazeutische plazebozusammensetzung , insbesondere auf basis von proteinen oder polypeptiden, zur nachahmung eines arzneimittels | |
DK1077717T3 (da) | Anvendelse af lipopeptider eller lipoproteiner til sårbehandling | |
RU95120588A (ru) | Циклогексапептиды, их смеси, способ их получения и применения | |
ECSP982660A (es) | USO DE ANALOGOS DEL PTHrP EN LA CICATRIZACION DE FRACTURAS | |
AR005559A1 (es) | Construccion peptidica que tiene un efecto potencializador de la actividad biologica de la hormona del crecimiento, acido nucleico recombinante, composicion que contiene dicha construccion peptidica y uso de dicha composicion y de dicho acido nucleico recombinante. | |
NZ224251A (en) | Synthetic rhinovirus (hrv) peptides and vaccines | |
YU64192A (sh) | Analozi insulina | |
Karpenko et al. | Study of bone tissue insoluble collagen hydrolysis by Streptomyces griseus protease using the method of N-terminal analysis | |
KR920700224A (ko) | 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제 | |
RU94036770A (ru) | Домен ингибитора протеазы, днк, вектор, клетка, способ получения домена, фармацевтическая композиция, применение домена | |
CA2315294A1 (fr) | Utilisation de peptides citrullines derives de la filaggrine dans le cadre du traitement de maladies autoimmunes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |